Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Calcifediol for Use in Treatment of Respiratory Disease. | Nutrients | 2022 | 35745177 | PubTator, text mining | PubMed |
| DIA-Based Proteomic Analysis of Plasma Protein Profiles in Patients with Severe Acute Pancreatitis. | Molecules | 2022 | 35745003 | PubTator, text mining | PubMed |
| An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes. | Microorganisms | 2022 | 35744609 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review. | Genes (Basel) | 2022 | 35741711 | PubTator, text mining | PubMed |
| The Challenges of Eradicating Pediatric Helicobacter pylori Infection in the Era of Probiotics. | Children (Basel) | 2022 | 35740732 | PubTator, text mining | PubMed |
| Is High Expression of Claudin-7 in Advanced Colorectal Carcinoma Associated with a Poor Survival Rate? A Comparative Statistical and Artificial Intelligence Study. | Cancers (Basel) | 2022 | 35740581 | PubTator, text mining | PubMed |
| The Potential Application and Promising Role of Targeted Therapy in Pulmonary Arterial Hypertension. | Biomedicines | 2022 | 35740436 | PubTator, text mining | PubMed |
| Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects. | Biomedicines | 2022 | 35740242 | PubTator, text mining | PubMed |
| Changing Perspectives from Oxidative Stress to Redox Signaling-Extracellular Redox Control in Translational Medicine. | Antioxidants (Basel) | 2022 | 35740078 | PubTator, text mining | PubMed |
| Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML. | In Vivo | 2022 | 35738590 | PubTator, text mining | PubMed |
| The Immunoregulatory Actions of DHEA in Tuberculosis, A Tool for Therapeutic Intervention? | Front Endocrinol (Lausanne) | 2022 | 35733782 | PubTator, text mining | PubMed |
| Antimicrobial Peptide Expression at the Ocular Surface and Their Therapeutic Use in the Treatment of Microbial Keratitis. | Front Microbiol | 2022 | 35722307 | PubTator, text mining | PubMed |
| Full-Length Transcriptome Sequencing Analysis of Differentially Expressed Genes and Pathways After Treatment of Psoriasis With Oxymatrine. | Front Pharmacol | 2022 | 35721124 | PubTator, text mining | PubMed |
| Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection. | Structure | 2022 | 35716662 | PubTator, text mining | PubMed |
| Expansion microscopy allows high resolution single cell analysis of epigenetic readers. | Nucleic Acids Res | 2022 | 35716125 | PubTator, text mining | PubMed |
| Post-neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage- and regression-grade independent prognostic information in intestinal-type gastric adenocarcinoma. | J Pathol Clin Res | 2022 | 35715937 | PubTator, text mining | PubMed |
| Proteome-Wide and Protein-Specific Multi-Epitope Vaccine Constructs Against the Rift Valley Fever Virus Outbreak Using Integrated Omics Approaches. | Front Microbiol | 2022 | 35711778 | PubTator, text mining | PubMed |
| Psoriasis: An Immunogenetic Perspective. | Glob Med Genet | 2022 | 35707771 | PubTator, text mining | PubMed |
| Correlation between salivary HBD-2 and LL-37 expression levels with blood glucose and periodontal status in patients with type 2 diabetes mellitus. | Am J Transl Res | 2022 | 35702098 | PubTator, text mining | PubMed |
| Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective BETi are strictly epigenetic transcriptional regulators. | Biomed Pharmacother | 2022 | 35687908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=39